Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer
Conditions
- Graft Versus Host Disease
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Diseases
- Secondary Myelofibrosis
Interventions
- BIOLOGICAL: anti-thymocyte globulin
- DRUG: busulfan
- DRUG: cyclophosphamide
- DRUG: mycophenolate mofetil
- DRUG: tacrolimus
- GENETIC: polymerase chain reaction
- GENETIC: polymorphism analysis
- OTHER: flow cytometry
- OTHER: laboratory biomarker analysis
- OTHER: pharmacogenomic studies
- OTHER: pharmacological study
- PROCEDURE: allogeneic bone marrow transplantation
- PROCEDURE: allogeneic hematopoietic stem cell transplantation
- PROCEDURE: peripheral blood stem cell transplantation
Sponsor
University of Nebraska
Collaborators